NCT00242541View on ClinicalTrials.gov

Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas

PHASE4TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2005

Conditions
Acromegaly
Interventions
DRUG

Octreotide acetate

Trial Locations (1)

Unknown

Novartis Investigative Site, Mexico City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY